4//SEC Filing
Vig Pamela 4
Accession 0001209191-22-002433
CIK 0001759425other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:56 PM ET
Size
7.9 KB
Accession
0001209191-22-002433
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-01-06+10,000→ 20,435 total - Award
Stock Option (right to buy)
2022-01-06+60,000→ 60,000 totalExercise: $15.87Exp: 2032-01-05→ Common Stock (60,000 underlying)
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/4th of the shares vest one year after January 6, 2022 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001780069
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:56 PM ET
- Size
- 7.9 KB